# Invasive mould infections of the central nervous system in the Indian population: a cohort study (2004–2025)

**Authors:** Harsimran Kaur, Shivaprakash M. Rudramurthy, Rimjhim Kanaujia, Haseen Ahmad, Pravin Salunke, Deepak Bansal, Kirti Gupta, Debajyoti Chatterjee, Chirag Kamal Ahuja, Aastha Takkar Kapila, Manish Modi, Sandeep Mohindra, Rajesh Chhabra, Madhivanan Karthigeyan, Harpreet Singh, Apinderpreet Singh, Ashish Agarwal, Sanjay Verma, Sunil Kumar Gupta, Sanjay Jain, Amita Trehan, Sameer Vyas, Vignesh Pandiarajan, Anup Ghosh, Arunaloke Chakrabarti

PMC · DOI: 10.1016/j.lansea.2026.100736 · The Lancet Regional Health - Southeast Asia · 2026-03-04

## TL;DR

This study examines mould infections in the brain among Indian patients, revealing patterns in age groups, fungal types, and treatment outcomes.

## Contribution

The study provides a large-scale cohort analysis of CNS invasive mould infections in India, identifying distinct clinical and treatment patterns.

## Key findings

- Melanized fungi predominantly infected adults, while Cladophialophora bantiana and Aspergillus spp. were common pathogens.
- Paediatric patients showed higher rates of frontal lobe involvement and partial surgical excision.
- Complete excision and lack of headache were associated with better survival outcomes.

## Abstract

Central nervous system (CNS) invasive mould infection (IMI) is a rare but life-threatening condition. Limited large-scale studies hinder the understanding of its clinical characteristics and optimal management strategies.

This was a cohort study. We reviewed confirmed patients of CNS IMI (January 2004–March 2025) by microbiological (direct microscopy and/or culture) and/or histopathological evidence at our tertiary care hospital. Clinical, demographic and mycological characteristics were analysed and compared.

Among 1321 brain abscess/biopsy samples, 127 patients (9.6%) were of fungal origin (adults, 100; paediatrics, 27). The median age was 30 (IQR: 27) years, with male predominance (71.7%). Adults were significantly infected by melanized fungi (p = 0.003). Seventy-four percent of patients had no identifiable underlying immunocompromising condition. The median duration of symptoms was 15 days (IQR: 23 days), including headache (61.4%) and seizures (50.4%). Frequency of fever was significantly higher in infection by melanized fungi (p = 0.02). Frontal lobe involvement was common in paediatric age (OR 0.379, 95% CI 0.141–1.019; p = 0.05). Aspergillus spp. (56.3%) and Cladophialophora bantiana (21.36%) were the predominant pathogens. Deniquelata barringtoniae was reported as a human pathogen. Voriconazole (61.4%) and liposomal amphotericin B (28.3%) were the primary antifungals used. Surgical intervention was performed in all patients. Partial excision (66.7% vs 38.0%, OR 0.306, 95% CI 0.125–0.751; p = 0.01) and use of liposomal amphotericin B (55.6% vs 21%, OR 0.213, 95% CI 0.087–0.522 p = 0.001) were common in paediatric patients. The overall mortality was 30.7%, complete excision was significantly more frequent among survivors than non-survivors (67.0% vs 30.8%; OR 0.218, 95% CI 0.097–0.492; p = 0.001). Lack of headache (p = 0.044) and partial excision surgery (p = 0.001) were independently associated with poor outcome.

We describe a compendium of CNS IMI in patients from India, highlighting distinct clinical patterns and treatment outcomes across age groups and fungal types. This warrants investigation of host and pathogen-related factors in the country.

Funding included Department of Science and Technology-Science and Engineering Research Board (DST-SERB), New Delhi, India and 10.13039/501100001411Indian Council of Medical Research (ICMR), New Delhi, India.

## Full-text entities

- **Genes:** HLA-B (major histocompatibility complex, class I, B) [NCBI Gene 3106] {aka AS, B-4901, HLAB}
- **Diseases:** paranasal sinusitis (MESH:D012852), SOL (MESH:D008158), mastoiditis (MESH:D008417), granulomatous (MESH:D013968), Head trauma (MESH:D006259), fibrosis (MESH:D005355), critically ill (MESH:D016638), vasculitis (MESH:D014657), disease (MESH:D004194), inflammation (MESH:D007249), abscess (MESH:D000038), liver disease (MESH:D008107), Headache (MESH:D006261), DM (MESH:D009223), meningitis (MESH:D008580), CNS space-occupying lesion (MESH:D002493), uncontrolled diabetes mellitus (MESH:D003920), Malignancy (MESH:D009369), temporal lobe or cerebellar abscesses (MESH:D004833), pituitary adenoma (MESH:D010911), Hodgkin's Lymphoma (MESH:D006689), S. commune infection (MESH:D017714), haemorrhage (MESH:D006470), cerebral edema (MESH:D001929), CGD (MESH:D006105), vomiting (MESH:D014839), otitis media (MESH:D010033), fever (MESH:D005334), AML (MESH:D015470), ischemia (MESH:D007511), Tetralogy of Fallot (MESH:D013771), seizures (MESH:D012640), C. bantiana (OMIM:211750), meningioma (MESH:D008579), immunodeficiency disease (MESH:D007153), melanized fungi (MESH:D008548), Mortality (MESH:D003643), gliosis (MESH:D005911), arthritis (MESH:D001168), Mucorales (MESH:D009091), aphasia (MESH:D001037), ventriculitis (MESH:D058565), hemiparesis (MESH:D010291), central nervous system (CNS) mycoses (MESH:D020314), immune dysfunction (MESH:D007154), -cell ALL (MESH:D054198), cerebral infarction (MESH:D002544), Acute lymphoblastic leukaemia (MESH:D054218), oedema (MESH:C536897), mycotic aneurysms (MESH:D000785), infected (MESH:D007239), granulomas (MESH:D006099), tuberculosis (MESH:D014376), phaeohyphomycosis (MESH:D060446), CNS aspergillosis (MESH:D020953), invasive aspergillosis (MESH:D055744), kidney disease (MESH:D007674), septic embolisms (MESH:D004617), Invasive (MESH:D009361), Infectious Diseases (MESH:D003141)
- **Chemicals:** MICA (MESH:C011934), azole (MESH:D001393), Micafungin (MESH:D000077551), Posaconazole (MESH:C101425), POS (MESH:D011059), Voriconazole (MESH:D065819), echinocandins (MESH:D054714), hematoxylin (MESH:D006416), Anidulafungin (MESH:D000077612), sulfasalazine (MESH:D012460), LCB (MESH:C062934), BHIA (-), AMB (MESH:D000666), KOH (MESH:C029943), melanin (MESH:D008543), Steroid (MESH:D013256), Itraconazole (MESH:D017964), triazoles (MESH:D014230), CAS (MESH:D002118), Caspofungin (MESH:D000077336), methenamine silver (MESH:D008709)
- **Species:** Purpureocillium lilacinum (species) [taxon 33203], Rhinocladiella mackenziei (species) [taxon 86056], Deniquelata (genus) [taxon 1343192], Aspergillus fumigatus (species) [taxon 746128], Aspergillus niger (species) [taxon 5061], Rhizopus arrhizus (species) [taxon 64495], Aspergillus terreus (species) [taxon 33178], Acrophialophora fusispora (species) [taxon 391091], Fungi (kingdom) [taxon 4751], A. flavus [taxon 315677], Aspergillus nidulans (species) [taxon 162425], Deniquelata vittalii (species) [taxon 2059719], Chaetomium (genus) [taxon 5149], Aspergillus flavus (species) [taxon 5059], Cladophialophora bantiana (species) [taxon 89940], Deniquelata barringtoniae (species) [taxon 1224812], Homo sapiens (human, species) [taxon 9606], Deniquelata hypolithi (species) [taxon 2831549], Rhizopus microsporus (species) [taxon 58291], Fusarium oxysporum (species) [taxon 5507]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12969336/full.md

## References

32 references — full list in the complete paper: https://tomesphere.com/paper/PMC12969336/full.md

---
Source: https://tomesphere.com/paper/PMC12969336